新型镇痛多肽Eb1.6的含量及有关物质检测

目的: 建立一种适用于新型alpha芋螺镇痛多肽Eb1.6含量及有关物质的分析方法,以及其水分和乙酸的含量测定方法.方法: 采用高效液相色谱法测定Eb1.6原料药中Eb1.6的含量.使用Zorbax XDB-C₁₈色谱柱(150 mm×4.6 mm,5 μm),流动相A为含0.1%三氟乙酸(TFA)的水,流动相B为含0.1%TFA的乙腈,梯度洗脱,流速1 mL·min^-1,检测波长214 nm,柱温25 ℃;采用卡尔菲休库仑滴定法及高效液相色谱法测定样品中水分及乙酸含量.结果: 3批Eb1.6原料药中Eb1.6含量范围在(98.85±0.63)%~(99.04±0.33)%之间(按无水物计算),总有关物质含量在0.45%~0.84%之间,样品中水分含量在(1.23±0.32)%~(2.23±0.23)%之间,乙酸含量在(11.16±0.08)%~(12.66±0.03)%之间.结论: 该方法快速简便,结果准确可靠,可用于Eb1.6的质量分析.

Objective: To established a method to determine the content of novel analgesic conopeptide Eb1.6 and its related substances as well as the content of moisture and acetic acid.Methods: Eb1.6 was detected with Zorbax Eclipse XDB-C₁₈ column(150 mm×4.6 mm, 5 μm)at the detection wavelength of 214 nm with the flow rate of 1.0 mL·min^-1.The mobile phase A was 0.1% TFA, the mobile phase B was 0.1% CH₃CN, the gradient elution was adopted.The column temperature was 25 ℃.The water content of Eb1.6 was determined by Karl Fischer coulometric titration method, and the content of acetic acid was determined by HPLC method.Results: The content of Eb1.6 in three batches of crude drugs was in the range of(98.85±0.63)% -(99.04±0.33)%(calculated by anhydride), while the content of total related substances was from 0.45% to 0.84%, the water content was(1.23±0.32)% -(2.23±0.23)% and the content of acetic acid was(11.16±0.08)% -(12.66±0.03)%.Conclusion: The method is reliable, accurate and specific.It can be used for quality analysis of Eb1.6.

[1] Lee MS.Recent progress in the discovery and development of N-type calcium channel modulators for the treatment of pain[J].Prog Med Chem,2014,53:147
[2] Pope JE,Deer TR.Ziconotide: a clinical update and pharmacologic review[J].Expert Opin Pharmacol Ther,2013,14(7):957
[3] Brady RM,Baell JB,Norton RS.Strategies for the development of conotoxins as new therapeutic leads[J].Mar Drugs,2013,11(7):2293
[4] Adams DJ,Berecki G.Mechanisms of conotoxin inhibition of N-type(Ca(v)2.2)calcium channels[J].Biochim Biophys Acta,2013,1828(7):1619
[5] Adams DJ,Callaghan B,Berecki G.Analgesic conotoxins: block and G protein-coupled receptor modulation of N-type(CaV2.2)calcium channels[J].Br J Pharmacol,2012,166(2):486
[6] LIU Zhu-guo(刘珠果),DAI Qiu-yun(戴秋云),SUN Ting(孙婷),et al.Applications of a-conotoxins(α型芋螺多肽及其应用): China(中国),201010121879.7[P].2011-05-25
[7] XU Yan(徐艳),YU Shuo(余硕),JI Hong-wei(姬泓巍),et al.Preparation method of conopeptide Eb1.6(芋螺多肽Eb1.6的制备工艺研究)[J].Mil Med Sci(军事医学),2013,37(4):274
[8] YU Shuo(余硕),GUO Hui-qin(郭会芹),FU Chao(付超),et al.Quality analysis of a novel HIV fusion inhibitor CP32M(抗HIV融合多肽CP32M的质量分析)[J].Mil Med Sci(军事医学),2012,36(11):839
[9] GUO Hui-qin(郭会芹),WANG Yu(王于),FU Chao(付超),et al.Quality analysis of novel anticoagulant peptide Hirulog-S(新型抗凝血多肽Hirulog-S的质量分析)[J].Chin J Pharm Anal(药物分析杂志),2011,31(10):1930[ZK)]
[10] ChP 2010.Vol Ⅱ(中国药典2010年版.二部)[S].2010:Appendix(附录)VD
[11] ChP 2010.Vol Ⅱ(中国药典2010年版.二部)[S].2010:Appendix(附录)Ⅷ M